The final webinar of the Fall series discussed what is known from social and behavioral science and community experience about the definitions and perceptions of HIV risk among women that are relevant to their potential PrEP use.
Avac Event
Risky Women: Disrupting simple notions of women’s HIV risk
Avac Event
PrEP-ception: Sero-discordant couples using PrEP to reduce HIV transmission risk during pregnancy
The second in a series of webinars by the US Women and PrEP Working Group discussed the possibilities and challenges associated with serodiscordant couples using PrEP to help them achieve pregnancy safely.
Avac Event
AIDS Vaccine 2013
AIDS Vaccine 2013 took place from October 7–10 in Barcelona, Spain. AIDS Vaccine is the largest global scientific conference focused exclusively on AIDS vaccine research. Hosted annually by the Global HIV Vaccine Enterprise and local partners, AIDS Vaccine brings together the best and brightest scientific minds to exchange the latest research findings, explore new ideas, educate future leaders and engage a diverse community to help further research to develop a safe and effective HIV vaccine.
For the full program, click here . And, much of the conference is available via webcast here.
Avac Event
Ready, Set, PrEP: Update on current research and rollout of PrEP for women in the US
The US Women and PrEP Working Group held a webinar to discuss the latest in research and rollout of PrEP for women in the US. To learn more about the US Women and PrEP Working Group (and hear about upcoming webinars), visit www.prepwatch.org.
Avac Event
HIV Prevention Europe Webinars: Rectal microbicides
The seventh webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, will focus on rectal microbicides. The presentation was followed by a Q&A session.
Avac Event
US Conference on AIDS
Thousands of community leaders, front-line workers, policy makers, physicians and advocates from throughout the US met for the United States Conference on AIDS (USCA). What follows is a short list of biomedical HIV prevention research and implementation-related sessions and links to the Black Treatment Action Network/PxROAR Advocates’ Roadmap and full conference program. (The Black Treatment Action Network is a project of the Black AIDS Institute.)
The BTAN/PxROAR Advocates’ Roadmap highlights workshops, seminars and roundtables on a range of issues such as HIV prevention advocacy, access to treatment, linkage to care and the treatment cascade. Advocates who attend Roadmap sessions at the conference are eligible for prizes. Click here for more information.
Sessions of interest for biomedical HIV prevention advocates included:
Saturday, September 7
- National Black Treatment Advocates Network pre-conference session: “Reaching Viral Suppression in the Black South”.
Sunday, September 8
- Workshop: Structural-level Interventions for HIV Prevention – Strategies for program implementation.
- Workshop: An HIV Cure: How close are we?.
Monday, September 9
- Workshop: Biomedical HIV Prevention as a Comprehensive Approach to Reaching an AIDS Free Generation.
Tuesday, September 10
- Workshop: PrEP Messaging.
Wednesday, September 11
Avac Event
New WHO guidelines on the use of ARVs for treating and preventing HIV
On June 30, the World Health Organization (WHO) released updated Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. AVAC, Global Network of People of Living with HIV (GNP+), the International HIV/AIDS Alliance (Alliance), and STOP AIDS NOW! (SAN!) held a webinar to discuss the guidelines and a new tool—Community Guide to Treatment as Prevention Programming.
The call included a brief overview of the guidelines by Gottfried Hirnschall, the Director of the Department of HIV/AIDS at WHO, as well as other resource people who were involved in the development of the guidelines and are engaged in translating these guidelines into practice.
In addition, Moono Nyambe from GNP+ discussed the “community” reactions toward the guidelines and described the collaborative effort led by GNP+, Alliance and SAN! to develop the Community Guide (to help communities understand the substance of the WHO guidelines and get involved in programming and implementation at country level).
Avac Event
Next Generation Condoms: European research and perpectives
The sixth webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, will focus on the next generation of male and female condoms being introduced to meet specific HIV prevention needs.
Avac Event
IAS 2013
Held every two years, the IAS Conference on HIV Pathogenesis, Treatment and Prevention includes many sessions on a range of HIV-related topics. Approximately 4,000 scientists, community leaders, public health experts and advocates met between June 30-July 3 in the Kuala Lumpur Convention Center.
The full conference schedule may be found on the IAS 2013 website along with a number of roadmaps that identify sessions focused on specific issues, including AIDS vaccines and biomedical prevention, treatment as prevention and towards an HIV cure.
In addition, we wanted to be sure to draw your attention to a few sessions taking place at IAS 2013 of particular interest to prevention research advocates:
Sunday, June 30
- Satellite: ARV-Based Prevention: State of the Art and Key Issues for a Multidisciplinary Research Agenda, 12:30-2:30, Mini Room 1
- Satellite: Launch of 2013 WHO Consolidated ARV Guidelines – What’s the Evidence? 14:45–16:45, Session Room 3
- Satellite: Expanding HIV Prevention Options for Women, 17:00–19:00, Mini Room 3 – Download the meeting report
Monday, July 1
- Oral Poster Session: Voluntary Medical Male Circumcision: Getting It Done, 13:00–14:00, Mini Room 1
Tuesday, July 2
- Symposium: New Approaches to Assess the Population Level Impact of New Prevention Technologies, 14:30–16:00, Session Room 3
- Symposium: HIV Vaccines and Future Strategies, 16:30–18:00, Session Room 3
Wednesday, July 3
- Late Breaker Track C: Prevention Sciences, including results of the recent Bangkok Tenofovir Study, other PrEP research, Implementing Option B+ in Malawi and the Shang Ring non-surgical VMMC device, 16:30-17:30, Session Room 1
For those not attending the conference in person, there were a number of ways to follow along at a distance. Once again NAM/AIDSMAP was the official provider of online scientific reporting from the conference. Clinical Care Options provided scientific analysis of the news announced in Kuala Lumpur. IAS provided “The Daily Bulletin” on their website with news and information from each day of the conference once the proceedings begin. You may also follow their Facebook page.
Avac Event
Thai Intravenous Drug User PrEP Trial Results
AVAC and the Harm Reduction Coalition organized a teleconference to discuss the recent results of the Bangkok Tenofovir Study, a Thai trial of pre-exposure prophylaxis in injecting drug users.
Presentations were followed by a Q&A session. Questions unanswered during the webinar are addressed in a supporting document, available here.
Also worth checking out, Beyond the Hype: PrEP for people who inject drugs by Daniel Wolfe.